Can’t Ignore: Providence Service Corp. (NASDAQ:PRSC), FLY Leasing Limited (NYSE:FLY), CLARCOR (NYSE:CLC), Sunesis Pharmaceuticals (NASDAQ:SNSS)

P&F Industries Inc. (NASDAQ:PFIN) shares moved up 0.10% in last trading session and ended the day at $10.50. PFIN Gross Margin is 37.30% and its has a return on assets of 4.50%. P&F Industries Inc. (NASDAQ:PFIN) quarterly performance is 22.24%.

P&f Industries (NASDAQ: PFIN) declared a special dividend of $0.50 per share. The dividend will be payable on April 4, 2016, to stockholders of record on March 21, 2016.

Providence Service Corp. (NASDAQ:PRSC) ended the last trading day at $52.75. Company weekly volatility is calculated as 7.25% and price to cash ratio as 7.60. Providence Service Corp. (NASDAQ:PRSC) showed a weekly performance of 9.87%.

The Providence Service Corporation (NASDAQ:PRSC) reported consolidated revenue of $424.9 million, an increase of 15.4% from $368.3 million in 2014. On a pro forma basis, assuming ownership of Matrix for all of the fourth quarter of 2014, consolidated revenue increased 10.2%.

On 11 March, FLY Leasing Limited (NYSE:FLY) shares moved up 2.13% and was closed at $12.96. FLY EPS growth in last 5 year was -14.50%. FLY Leasing Limited (NYSE:FLY) year to date (YTD) performance is -5.05%.

Fly Leasing Limited (NYSE: FLY) reported Q4 EPS of $1.54, $0.72 better than the analyst estimate of $0.82. Revenue for the quarter came in at $139 million versus the consensus estimate of $123.7 million. The

CLARCOR Inc. (NYSE:CLC) shares moved up 2.25% in last trading session and ended the day at $51.70. CLC Gross Margin is 33.00% and its has a return on assets of 7.20%. CLARCOR Inc. (NYSE:CLC) quarterly performance is 8.09%.

CLARCOR Inc. (NYSE:CLC) said it will release financial results for the first quarter of its 2016 fiscal year on Wednesday, March 16, 2016, after the close of trading on the New York Stock Exchange.

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) caters to the Healthcare space. Its weekly performance is -8.27%. On the last day of trading company shares ended up at $0.64.

On 10 March, Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS) reported a loss of $11.6 million in its fourth quarter. On a per-share basis, the South San Francisco, California-based company said it had a loss of 15 cents. The biopharmaceutical company posted revenue of $670,000 in the period. For the year, the company reported that its loss narrowed to $36.7 million, or 50 cents per share. Revenue was reported as $3.1 million.